Psychotropic Medications for Bipolar Disorder in Pregnancy

2019 ◽  
Vol 49 (9) ◽  
pp. 392-398
Author(s):  
Andrea Favini ◽  
Sarah Homitsky
2015 ◽  
Vol 7 ◽  
pp. CMT.S18902
Author(s):  
David M. Haas ◽  
Katherine W. McHugh ◽  
Paula J. Durst ◽  
Sarah M. Rose ◽  
Avinash S. Patil

Many pregnant women suffer from mental health conditions while pregnant. As providers and patients make decisions about risks of the conditions and treatments during pregnancy, information to populate those discussions is needed. Taking into account the physiologic changes in pregnancy, we may need to optimize medication therapy. This article reviews and summarizes some of the most common mental health conditions suffered in pregnancy: depression, bipolar disorder, anxiety, and psychosis. It further discusses the different medications used to treat them, as well as risks associated with these medications.


Ob Gyn News ◽  
2005 ◽  
Vol 40 (3) ◽  
pp. 11
Author(s):  
DIANA MAHONEY

2008 ◽  
Vol 59 (10) ◽  
pp. 1175-1183 ◽  
Author(s):  
Ross Baldessarini ◽  
Henry Henk ◽  
Ami Sklar ◽  
Jane Chang ◽  
Leslie Leahy

2020 ◽  
Vol 66 (3) ◽  
pp. 225-231 ◽  
Author(s):  
Liana Suparare ◽  
Stuart J Watson ◽  
Ray Binns ◽  
Jacqueline Frayne ◽  
Megan Galbally

Objective: To examine the risk of past and current experiences of intimate partner violence (IPV) in women with severe mental illness (SMI) in pregnancy. Methods: We examined past and current experiences of IPV in women with SMI in pregnancy. The data of 304 women with SMI including schizophrenia and related psychotic disorders and Bipolar Disorder meeting International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM) criteria were extracted from hospital records at King Edward Memorial Hospital, Western Australia. Comparisons were made between our study data and the Australian population data reported by the Australian Bureau of Statistics, which included data on pregnant women in Western Australia. Additional measures included reported demographics, substance use and pregnancy variables. Results: Around 48% of pregnant women with SMI had experienced IPV and were three times the risk when compared with the general pregnant population in Australia. There was no difference in rates of IPV in those women with psychotic disorders when compared with bipolar disorder. Furthermore, the rates of smoking and illicit substance use were significantly higher in pregnant women with SMI who experienced IPV compared with those who have not experienced IPV. Conclusion: These findings suggest women with SMI in pregnancy are at significantly higher risk of having experienced or experiencing IPV. In addition, IPV in pregnant women with SMI may increase the risk of smoking and illicit substance use. Together this suggests that maternity and mental health services should ensure there are both screening and support pathways for IPV that are developed and evaluated specifically for pregnant women with SMI.


The Lancet ◽  
2014 ◽  
Vol 384 (9956) ◽  
pp. 1789-1799 ◽  
Author(s):  
Ian Jones ◽  
Prabha S Chandra ◽  
Paola Dazzan ◽  
Louise M Howard

2013 ◽  
Vol 3 (2) ◽  
pp. 83-87 ◽  
Author(s):  
Thea Moore ◽  
Jennifer Pytlarz

Though approximately 15 to 29% of pregnant patients have a psychiatric disorder during pregnancy, only about 5 to 14% seek treatment. Untreated mental illness during pregnancy has been associated with poor nutrition, failure to follow prenatal and medical guidelines, and alcohol or other substance misuse. The risks of untreated mental illness during pregnancy must be carefully evaluated along with the risks posed by medications. This review will evaluate consequences of untreated depression, anxiety, schizophrenia, and bipolar disorder in the pregnant patient.


10.5080/u6131 ◽  
2010 ◽  
Author(s):  
Sinan Guloksuz ◽  
Fisun Akdeniz ◽  
Bahri Ince ◽  
Esat Timucin Oral

Sign in / Sign up

Export Citation Format

Share Document